The present treatment and mechanism progress of arsenic trioxide in hematological malignancies

Journal Title: Traditional Medicine Research - Year 2016, Vol 1, Issue 3

Abstract

This paper reviewed the development history of arsenic trioxide (ATO), and summarized its mechanisms and clinical application in the treatment of hematologic malignancies. ATO can induce tumor cell apoptosis, tumor cell differentiation and play a role in the treatment of malignant tumor of the blood system. Arsenic trioide (ATO) is a kind of highly toxic substances and the main effective components of arsenic. ATO has been used medicinally for over 2400 years. Recent years, many studies have found that ATO has a significant efficacy on the acute promyelocytic leukemia (APL). To further explore the latest findings of research on the treatment of hematologic malignanies of ATO, this paper reviewed the development history of ATO, and summarized its mechanisms and clinical application in the treatment of hematologic malignancies. In addition, we want to provide new ideas for researches on the treatment of cancer of ATO.

Authors and Affiliations

Liu Lin, Zhao Zhi-Gang

Keywords

Related Articles

Screening for cyclooxygenase 2 inhibitors from natural compounds of Radix Glycyrrhizae using computer simulation

Objective: To explore the molecular basis of the effects of Gancao (Radix Glycyrrhizae, GC) on inflammation through the inhibition of cyclooxygenase 2 (COX-2). Methods: The Discovery Studio 4.5 System was used to predict...

Assessing acupuncture effect in the real world study

Acupuncture, with its unique set of theories and its evident results in clinical practice is an important part of traditional Chinese medicine (TCM), and gaining recognition worldwide for the past few years. Although acu...

Epigenetic regulations of hematopoietic stem cells ageing and the regulation of traditional Chinese medicine

The current progress in the study of DNA methylation and histone modifications regulating HSCs ageing and the epigenetic role of TCM in the treatment of hematological malignancies were summarized. Age-related defects...

Challenges and opportunities of applying P4 medicine and traditional Chinese medicine for cancer treatment and prevention in the 21st century: A medical oncologist’s perspectives

Being one of the deadliest diseases, cancer needs a stronger dose of P4 medicine (Predictive, Preventive, Personalized and Participatory) first proposed by Dr. Hood and TCM intervention, as cancer treatment still largely...

A Hemorrhoids Topical Formula

Composition Wu Mei (Fructus Mume) 30g, Huang Lian (Rhizoma Picrorhizae) 10g, Ce Bai Ye (Cacumen Platycladi) 10g (stir-bake to scorch), Sheng Da Huang (Radix et Rhizoma Rhei) 10g (decoct later), Ku Shen (Radix Sophorae...

Download PDF file
  • EP ID EP45286
  • DOI 10.12032/TMR201603016
  • Views 271
  • Downloads 0

How To Cite

Liu Lin, Zhao Zhi-Gang (2016). The present treatment and mechanism progress of arsenic trioxide in hematological malignancies. Traditional Medicine Research, 1(3), -. https://europub.co.uk/articles/-A-45286